Comparing the Cost of Rotigotine API from Different Regions
30 May 2024 //
PRESS RELEASE
Mitigating Shortages Strategies for Rotigotine Stable Supply
08 May 2024 //
PRESS RELEASE
Understanding the Chemical Properties of Rotigotine API
03 Apr 2024 //
PRESS RELEASE
The Uses of Rotigotine in Parkinson’s Disease Treatment
24 Jan 2024 //
PRESS RELEASE
UCB`s second shot at Neupro patent validation fails on appeal
13 Apr 2023 //
FIERCE PHARMA
XPhyto Reports Excellent Rotigotine In-Vitro/Ex-Vivo Results for Parkinson
18 Oct 2022 //
ACCESSWIRE
XPhyto Reports Platform-Based Rotigotine Transdermal Patch for PD
09 May 2022 //
ACCESSWIRE
XPhyto Reports Product Developments on Rotigotine Transdermal Patch for PD
04 Apr 2022 //
ACCESSWIRE
XPhyto Reports Development Update for its Drug Delivery Business
12 Oct 2021 //
ACCESSWIRE
Letters and drug alerts sent to healthcare professionals in July 2019
19 Aug 2019 //
GOVUK
Watchdog sues FDA for stalling on Parkinson`s drug warnings
01 May 2019 //
FIERCE PHARMA
China FDA ahead for UCB`s Neupro after PhIII Parkinson`s results
18 Jun 2015 //
FIERCE PHARMA ASIA